A product that a CTIMP generates information about is referred to as an Investigational Medicinal Product (IMP). This includes studies of licensed medicinal products, if they will be used in any way ...

The controlled cell line combined with Recipharm’s AAV manufacturing platform is said to allow for consistent and scalable ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) seeking accelerated approval for clemidsogene ...

A product that a CTIMP generates information about is referred to as an Investigational Medicinal Product (IMP). This includes studies of licensed medicinal products, if they will be used in any way ...